Sutro Biopharma, Inc. (STRO) Profit Margin
Sutro Biopharma, Inc. (STRO) net profit margin by fiscal period. Analyze profit margins in Excel with MarketXLS.
Profit Margin Data
| Period | Net Profit Margin |
|---|---|
| 2018-12-31 | -91.93% |
| 2019-12-31 | -130.44% |
| 2020-12-31 | -75.20% |
| 2021-12-31 | -170.55% |
| 2022-12-31 | -175.89% |
| 2023-12-31 | -69.47% |
| 2024-12-31 | -366.62% |
| 2025-12-31 | -186.45% |
How STRO compares with sector peers
| Symbol | Company | Net profit margin (latest fiscal year) |
|---|---|---|
| ENTA | Enanta Pharmaceuticals Inc. | -125.36% |
| MRNA | Moderna Inc. | -145.16% |
| IOVA | Iovance Biotherapeutics Inc. | -148.39% |
| VERU | Veru Inc. | -223.86% |
| DYAI | Dyadic International Inc. | -238.31% |
These are five companies in the same sector as STRO with a comparable annual net profit margin. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Sutro Biopharma, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Profit_Margin("STRO", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | STRO | $20.48 | +0.00% | 0.55M |
| 3 | ||||
| 4 | ||||
| 5 |